Showing results (1-10 of 410) with videos related to
Sort By:
Pageof 41
Best Practice & Research. Clinical Haematology|November 30, 2019
Which novel agents hold the greatest promise in AML?Courtney D DiNardoBlood Cancer Journal|August 16, 2025
Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithmsNaseema Gangat, Courtney D DinardoBest Practice & Research. Clinical Haematology|June 18, 2019
Hereditary myeloid malignanciesHind Rafei, Courtney D DiNardoClinical Lymphoma, Myeloma & Leukemia|November 13, 2018
SOHO State of the Art Update and Next Questions: IDH Therapeutic Targeting in AMLCourtney D DiNardo, Eytan M SteinTherapeutic Advances in Hematology|November 7, 2019
Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapyGuillaume Richard-Carpentier, Courtney D DiNardoBlood|November 26, 2019
How I treat acute myeloid leukemia in the era of new drugsCourtney D DiNardo, Andrew H WeiInternational Journal of Molecular Sciences|June 2, 2016
Hereditary Predispositions to Myelodysplastic SyndromeSarah A Bannon, Courtney D DiNardoCurrent Opinion in Hematology|May 18, 2010
Treatment advances in posttransplant lymphoproliferative diseaseCourtney D DiNardo, Donald E TsaiExpert Opinion on Pharmacotherapy|December 7, 2014
New treatment for acute myelogenous leukemiaCourtney D DiNardo, Jorge E CortesHematology. American Society of Hematology. Education Program|December 7, 2019
Single-agent and combination biologics in acute myeloid leukemiaGuillaume Richard-Carpentier, Courtney D DiNardoPageof 41